The GSK, Amgen and Novo-backed cancer drug developer went public in an upsized offering priced above its range.

Meituan Dianping is the largest investor in the China-based smart electric vehicle producer, which has set a $100m placeholder target for its initial public offering.

Primary care network Oak Street Health has filed for a $100m offering on the New York Stock Exchange that will give Humana an exit.

New World Development and China Mobile-backed gay social and dating app developer Blued raised $84.8m and has seen its shares nearly double in price post-IPO.

The Crooz, InterWorks, MyNavi, Sega Sammy and Vector-backed IT human resources provider could raise up to $21m in its initial public offering.

CAS-backed AI processor provider Cambricon, valued at $2.5bn in 2018, floated on Shanghai's Star Market.

Baylor College spinout AlloVir has filed to raise up to $100m in an offering that will support the clinical development of a treatment for viral diseases.

Alibaba's financial services spinoff is reportedly lining up an offering this year that would also represent an exit for China Life and China Post.

Lenovo, iFlytek, Alibaba and Tuling Century-backed AI processor provider Cambricon, valued at $2.5bn in 2018, floated on Shanghai's Star Market.

The co-working space provider, which counts a slew of corporates among its investors, will list on Nasdaq by merging with a SPAC in a deal jointly valuing them at $769m.